TrialOncotarget2015

SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma.

Yeon-Su Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.